NeoGenomics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $159.6M | $367.0M | $342.5M | $263.2M | $316.8M | $228.7M | $173.0M | $9.8M |
| Accounts Receivable | $159.2M | $150.5M | $131.2M | $119.7M | $112.1M | $106.8M | $94.2M | $76.9M |
| Inventory | $28.6M | $26.7M | $24.2M | $24.3M | $23.4M | $29.5M | $14.4M | $8.7M |
| Total Current Assets | $376.3M | $596.0M | $596.8M | $605.3M | $681.5M | $448.7M | $290.7M | $103.7M |
| Property, Plant & Equipment | $84.8M | $94.1M | $92.0M | $102.5M | $109.5M | $85.9M | $64.2M | $60.9M |
| Goodwill | $524.3M | $522.8M | $522.8M | $522.8M | $527.1M | $211.1M | $198.6M | $197.9M |
| Intangible Assets (Excl. Goodwill) | $286.5M | $339.7M | $373.1M | $408.3M | $442.3M | $120.7M | $126.6M | $140.0M |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988.3M | $709.5M | $505.0M |
| Liabilities | ||||||||
| Accounts Payable | $23.1M | $21.6M | $20.3M | $20.5M | $17.9M | $25.0M | $19.6M | $17.8M |
| Total Current Liabilities | $88.3M | $301.2M | $96.3M | $89.9M | $87.2M | $73.2M | $63.9M | $60.9M |
| Long-Term Debt | $341.9M | $340.3M | $538.2M | $535.3M | $532.6M | $169.1M | $95.0M | $92.9M |
| Total Liabilities | $523.3M | $735.7M | $739.7M | $742.0M | $761.5M | $294.0M | $202.1M | $184.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-433.8M | $-325.8M | $-247.1M | $-159.1M | $-14.8M | $-7.2M | $-11.4M | $-19.4M |
| Total Stockholders' Equity | $836.6M | $902.3M | $941.5M | $998.0M | $1.11B | $694.3M | $507.4M | $320.4M |